Invention Grant
- Patent Title: Compounds for enzyme inhibition
-
Application No.: US13646491Application Date: 2012-10-05
-
Publication No.: US08765745B2Publication Date: 2014-07-01
- Inventor: Kevin D. Shenk , Francesco Parlati , Han-jie Zhou , Catherine Sylvain , Mark S. Smyth , Mark K. Bennett , Guy J. Laidig
- Applicant: Onyx Therapeutics, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Onyx Therapeutics, Inc.
- Current Assignee: Onyx Therapeutics, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Marshall, Gerstein & Borun LLP
- Main IPC: A61K31/5377
- IPC: A61K31/5377
Abstract:
One aspect of the invention relates to inhibitors that preferentially inhibit immunoproteasome activity over constitutive proteasome activity. In certain embodiments, the invention relates to the treatment of immune related diseases, comprising administering a compound of the invention. In certain embodiments, the invention relates to the treatment of cancer, comprising administering a compound of the invention.
Public/Granted literature
- US20130053303A1 COMPOUNDS FOR ENZYME INHIBITION Public/Granted day:2013-02-28
Information query
IPC分类:
